Abstract
The correlation between metronidazole MIC readings obtained in vitro on two different media for two different inoculum dilutions was studied after two, three, and five days of incubation using 20 clinical isolates ofHelicobacter pylori. The PDM epsilometer (E test) was used. After two days of incubation, log MIC values on chocolate PDM and Vestfold charcoal medium, a new charcoal medium, showed good correlation. Charcoal media can thus be used for metronidazole sensitivity tests. In terms of double-dilution gradients, prolongation of incubation time from two to three days and change of inoculum dilution from 0.5 to 4 McFarland had little impact when studied separately. However, the combined effect of the two variables was marked. The matching of a sparse inoculum incubated for two days against a heavy inoculum incubated for three days resulted in readings which, for 30% of the pairs, differed by two double-dilution gradients or more. On the other hand, the separate influence of both variables was found to affect the correlation coefficients significantly. Five days of incubation was associated with a poor correlation when the variables were studied both separately and combined. Thus, the real influence of separate variables on MIC readings was not exposed in a scale of double-dilution gradients because the intervals were too large. For this reason, scales without thresholds are recommended.
Similar content being viewed by others
References
Glupczynski Y: Results of a multicenter European survey in 1991 of metronidazole resistance inHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 777–781.
Glupczynski Y, Burette A: Drug therapy forHelicobacter pylori infection: problems and pitfalls. American Journal of Gastroenterology 1990, 85: 1545–1551.
Talley NJ, Noack KB: The worldwide prevalence ofHelicobacter pylori: asymptomatic infection and clinical states associated with infection in adults. In: Goodwin CS (ed):Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, FL, 1993, p. 63–83.
Becx MCJM, Janssen AJHM, Clasener HAL, de Koning RW: Metronidazole-resistantHelicobacter pylori. Lancet 1990, 335: 539–540.
Glupczynski Y, Burette A, de Koster E, Nyst JF, Deltenre M, Cadranel S, Bordeaux L, de Vos D: Metronidazole resistance inHelicobacter pylori. Lancet 1990, 335: 976–977.
Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GNJ: Impact of metronidazole resistance on the eradication ofHelicobacter pylori. Scandinavian Journal of Infectious Diseases 1994, 26: 321–327.
Rautelin H, Säppäla K, Renkonen OV, Vainio U, Kosunen TU: Role of metronidazole resistance in therapy ofHelicobacter pylori infections. Antimicrobial Agents and Chemotherapy 1992, 36: 163–166.
Bell GP, Powell K, Burridge SM, Pallecoras A, Jones PH, Gant PW, Harrison G, Trowell JE: Experience with “triple” anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Alimentary Pharmacology and Therapeutics 1992, 6: 427–435.
Goodwin CS: The susceptibility ofHelicobacter pylori to antibiotics. In: Goodwin CS (ed):Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, FL, 1993, p. 343–349.
Berstad A, Berstad K, Hatlebakk JG, Wilhelmsen I, Nysæter G, Bang CJ, Hausken T, Nesje LB, Hjartholm AS: Ti dagers trippelkur forHelicobacter pylori-inieksjon og magesår. Tidsskrift for Den Norske Laegeforening 1994, 114: 2477–2479.
Aursnes I: Norsk oppdateringskonferanse om behandling avHelicobacter pylori ved ulcus pepticum. Tidsskrift for Den Norske Laegeforening 1994, 114: 2495–2497.
Knapp CC, Ludwig MD, Washington JA: In vitro activity of metronidazole againstHelicobacter pylori as determined by agar dilution and agar diffusion. Antimicrobial Agents and Chemotherapy 1991, 35: 1230–1231.
Cederbrant G, Kahlmeter G, Ljungh Å: The E test for antimicrobial susceptibility testing ofHelicobacter pylori. Journal of Antimicrobial Chemotherapy 1993, 31: 65–71.
Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E: Evaluation of the E test for quantitative antimicrobial susceptibility testing forHelicobacter pylori. Journal of Clinical Microbiology 1991, 29: 2072–2075.
Henriksen TH, Brorson Ö, Schöyen R, Thoresen T, Setegn D, Madebo T: Rapid growth ofHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 1008–1011.
Westblom TU, Madan E, Midkiff BR: Egg yolk emulsion agar, a new medium for the cultivation ofHelicobacter pylori. Journal of Clinical Microbiology 1991, 29: 819–821.
Cederbrant G, Kahlmeter G, Ljungh Å: Proposed mechanism for metronidazole resistance inHelicobacter pylori. Journal of Antimicrobial Chemotherapy 1992, 29: 115–120.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henriksen, T.H., Brorson, Ö., Schöyen, R. et al. Risks related to lack of standardization of tests to detect in vitro metronidazole resistance inHelicobacter pylori . Eur. J. Clin. Microbiol. Infect. Dis. 15, 484–488 (1996). https://doi.org/10.1007/BF01691316
Issue Date:
DOI: https://doi.org/10.1007/BF01691316